Top

Respiratory Research

Published in:

Open Access 01-12-2022 | Research

Functional changes in long-term incubated rat precision-cut lung slices

Authors: Sarah Marie Nußbaum, Julia Krabbe, Svenja Böll, Aaron Babendreyer, Christian Martin

Published in: Respiratory Research | Issue 1/2022

Abstract

Background

Respiratory diseases represent a global health burden. Because research on therapeutic strategies of airway diseases is essential, the technique of precision-cut lung slices (PCLS) has been developed and widely studied. PCLS are an alternative ex vivo model and have the potential to replace and reduce in vivo animal models. So far, the majority of studies was conducted with short-term cultivated PCLS (≤ 72 h). As there is large interest in research of chronic diseases and chronic toxicity, feasibility of cultivating human PCLS long-term over 2 weeks and recently over 4 weeks was investigated by another research group with successful results. Our aim was to establish a model of long-term cultivated rat PCLS over a period of 29 days.

Methods

Rat PCLS were cultured for 29 days and analysed regarding viability, histopathology, reactivity and gene expression at different time points during cultivation.

Results

Cultivation of rat PCLS over a 29-day time period was successful with sustained viability. Furthermore, the ability of bronchoconstriction was maintained between 13 and 25 days, depending on the mediator. However, reduced relaxation, altered sensitivity and increased respiratory tone were observed. Regarding transcription, alteration in gene expression pattern of the investigated target genes was ascertained during long-term cultivation with mixed results. Furthermore, the preparation of PCLS seems to influence messenger ribonucleic acid (mRNA) expression of most target genes. Moreover, the addition of fetal bovine serum (FBS) to the culture medium did not improve viability of PCLS. In contrast to medium without FBS, FBS seems to affect measurements and resulted in marked cellular changes of metaplastic and/or regenerative origin.

Conclusions

Overall, a model of long-term cultivated rat PCLS which stays viable for 29 days and reactive for at least 13 days could be established. Before long-term cultivated PCLS can be used for in-depth study of chronic diseases and chronic toxicity, further investigations have to be made.

Available only for authorised users

World Health Organization (WHO): The top 10 causes of death. 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 23 Feb 2021.

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396:1204–1222.

Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J. 2013;42:559–63. https://doi.org/10.1183/09031936.00105513.CrossRefPubMed

Held HD, Martin C, Uhlig S. Characterization of airway and vascular responses in murine lungs. Br J Pharmacol. 1999;126:1191–9. https://doi.org/10.1038/sj.bjp.0702394.CrossRefPubMedPubMedCentral

Martin C, Uhlig S, Ullrich V. Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices. Eur Respir J. 1996;9:2479–87. https://doi.org/10.1183/09031936.96.09122479.CrossRefPubMed

Martin C, Ullrich V, Uhlig S. Effects of the thromboxane receptor agonist U46619 and endothelin-1 on large and small airways. Eur Respir J. 2000;16:316–23. https://doi.org/10.1034/j.1399-3003.2000.16b21.x.CrossRefPubMed

Ressmeyer AR, Larsson AK, Vollmer E, Dahlèn SE, Uhlig S, Martin C. Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J. 2006;28:603–11. https://doi.org/10.1183/09031936.06.00004206.CrossRefPubMed

Seehase S, Schleputz M, Switalla S, Matz-Rensing K, Kaup FJ, Zoller M, Schlumbohm C, Fuchs E, Lauenstein HD, Winkler C, et al. Bronchoconstriction in nonhuman primates: a species comparison. J Appl Physiol. 1985;2011(111):791–8. https://doi.org/10.1152/japplphysiol.00162.2011.CrossRef

Paddenberg R, Mermer P, Goldenberg A, Kummer W. Videomorphometric analysis of hypoxic pulmonary vasoconstriction of intra-pulmonary arteries using murine precision cut lung slices. J Vis Exp. 2014. https://doi.org/10.3791/50970.CrossRefPubMedPubMedCentral

10.

Rieg AD, Bünting NA, Cranen C, Suleiman S, Spillner JW, Schnöring H, Schröder T, von Stillfried S, Braunschweig T, Manley PW, et al. Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices. Respir Res. 2019;20:111. https://doi.org/10.1186/s12931-019-1074-2.CrossRefPubMedPubMedCentral

11.

Rieg AD, Rossaint R, Verjans E, Maihöfer NA, Uhlig S, Martin C. Levosimendan relaxes pulmonary arteries and veins in precision-cut lung slices—the role of KATP-channels, cAMP and cGMP. PLoS ONE. 2013;8: e66195. https://doi.org/10.1371/journal.pone.0066195.CrossRefPubMedPubMedCentral

12.

Delmotte P, Sanderson MJ. Ciliary beat frequency is maintained at a maximal rate in the small airways of mouse lung slices. Am J Respir Cell Mol Biol. 2006;35:110–7. https://doi.org/10.1165/rcmb.2005-0417OC.CrossRefPubMedPubMedCentral

13.

Wohlsen A, Martin C, Vollmer E, Branscheid D, Magnussen H, Becker WM, Lepp U, Uhlig S. The early allergic response in small airways of human precision-cut lung slices. Eur Respir J. 2003;21:1024–32. https://doi.org/10.1183/09031936.03.00027502.CrossRefPubMed

14.

Lauenstein L, Switalla S, Prenzler F, Seehase S, Pfennig O, Förster C, Fieguth H, Braun A, Sewald K. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro. 2014;28:588–99. https://doi.org/10.1016/j.tiv.2013.12.016.CrossRefPubMed

15.

Nassimi M, Schleh C, Lauenstein HD, Hussein R, Hoymann HG, Koch W, Pohlmann G, Krug N, Sewald K, Rittinghausen S, et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm. 2010;75:107–16. https://doi.org/10.1016/j.ejpb.2010.02.014.CrossRefPubMed

16.

Paranjpe M, Neuhaus V, Finke JH, Richter C, Gothsch T, Kwade A, Büttgenbach S, Braun A, Müller-Goymann CC. In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal Toxicol. 2013;25:536–43. https://doi.org/10.3109/08958378.2013.810315.CrossRefPubMed

17.

Cooper PR, Zhang J, Damera G, Hoshi T, Zopf DA, Panettieri RA Jr. C-027 inhibits IgE-mediated passive sensitization bronchoconstriction and acts as a histamine and serotonin antagonist in human airways. Allergy Asthma Proc. 2011;32:359–65. https://doi.org/10.2500/aap.2011.32.3460.CrossRefPubMed

18.

Banerjee A, Trivedi CM, Damera G, Jiang M, Jester W, Hoshi T, Epstein JA, Panettieri RA Jr. Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. Am J Respir Cell Mol Biol. 2012;46:132–8. https://doi.org/10.1165/rcmb.2010-0276OC.CrossRefPubMedPubMedCentral

19.

Alsafadi HN, Uhl FE, Pineda RH, Bailey KE, Rojas M, Wagner DE, Königshoff M. Applications and approaches for three-dimensional precision-cut lung slices. Disease modeling and drug discovery. Am J Respir Cell Mol Biol. 2020;62:681–91. https://doi.org/10.1165/rcmb.2019-0276TR.CrossRefPubMedPubMedCentral

20.

Wu W, Booth JL, Duggan ES, Wu S, Patel KB, Coggeshall KM, Metcalf JP. Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology. 2010;396:178–88. https://doi.org/10.1016/j.virol.2009.10.016.CrossRefPubMed

21.

Zmora P, Molau-Blazejewska P, Bertram S, Walendy-Gnirß K, Nehlmeier I, Hartleib A, Moldenhauer AS, Konzok S, Dehmel S, Sewald K, et al. Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin. PLoS ONE. 2017;12: e0176597. https://doi.org/10.1371/journal.pone.0176597.CrossRefPubMedPubMedCentral

22.

Gerckens M, Alsafadi HN, Wagner DE, Lindner M, Burgstaller G, Königshoff M. Generation of human 3D lung tissue cultures (3D-LTCs) for disease modeling. J Vis Exp. 2019. https://doi.org/10.3791/58437.CrossRefPubMed

23.

Henjakovic M, Sewald K, Switalla S, Kaiser D, Müller M, Veres TZ, Martin C, Uhlig S, Krug N, Braun A. Ex vivo testing of immune responses in precision-cut lung slices. Toxicol Appl Pharmacol. 2008;231:68–76. https://doi.org/10.1016/j.taap.2008.04.003.CrossRefPubMed

24.

Neuhaus V, Schaudien D, Golovina T, Temann UA, Thompson C, Lippmann T, Bersch C, Pfennig O, Jonigk D, Braubach P, et al. Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality. J Occup Med Toxicol. 2017;12:13. https://doi.org/10.1186/s12995-017-0158-5.CrossRefPubMedPubMedCentral

25.

Temann A, Golovina T, Neuhaus V, Thompson C, Chichester JA, Braun A, Yusibov V. Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices. Hum Vaccin Immunother. 2017;13:351–8. https://doi.org/10.1080/21645515.2017.1264794.CrossRefPubMed

26.

Preuß EB, Schubert S, Werlein C, Stark H, Braubach P, Höfer A, Plucinski EKJ, Shah HR, Geffers R, Sewald K, et al. The challenge of long-term cultivation of human precision-cut lung slices. Am J Pathol. 2022;192:239–53. https://doi.org/10.1016/j.ajpath.2021.10.020.CrossRefPubMed

27.

Schlepütz M, Uhlig S, Martin C. Electric field stimulation of precision-cut lung slices. J Appl Physiol. 1985;2011(110):545–54. https://doi.org/10.1152/japplphysiol.00409.2010.CrossRef

28.

Martin C, Uhlig S, Ullrich V. Cytokine-induced bronchoconstriction in precision-cut lung slices is dependent upon cyclooxygenase-2 and thromboxane receptor activation. Am J Respir Cell Mol Biol. 2001;24:139–45. https://doi.org/10.1165/ajrcmb.24.2.3545.CrossRefPubMed

29.

Toni LS, Garcia AM, Jeffrey DA, Jiang X, Stauffer BL, Miyamoto SD, Sucharov CC. Optimization of phenol-chloroform RNA extraction. MethodsX. 2018;5:599–608. https://doi.org/10.1016/j.mex.2018.05.011.CrossRefPubMedPubMedCentral

30.

Uhlig S, Martin C. Bronchial Asthma. In: Offermanns S, Rosenthal W, editors. Encyclopedia of molecular pharmacology. 2nd ed. Berlin: Springer Verlag; 2008. p. 284–9. https://doi.org/10.1007/978-3-540-38918-7_237.CrossRef

31.

Uhl FE, Vierkotten S, Wagner DE, Burgstaller G, Costa R, Koch I, Lindner M, Meiners S, Eickelberg O, Königshoff M. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J. 2015;46:1150–66. https://doi.org/10.1183/09031936.00183214.CrossRefPubMed

32.

Song X, Hu W, Yu H, Wang H, Zhao Y, Korngold R, Zhao Y. Existence of circulating mitochondria in human and animal peripheral blood. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21062122.CrossRefPubMedPubMedCentral

33.

Gstraunthaler G. Alternatives to the use of fetal bovine serum: serum-free cell culture. Altex. 2003;20:275–81. https://doi.org/10.14573/altex.2003.4.257.CrossRefPubMed

34.

Ayache S, Panelli MC, Byrne KM, Slezak S, Leitman SF, Marincola FM, Stroncek DF: Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion. J Transl Med 2006, 4:40. https://doi.org/10.1186/1479-5876-4-40

35.

Gstraunthaler G, Lindl T. Zell- und Gewebekultur. 7th ed. Berlin: Springer Verlag; 2013. https://doi.org/10.1007/978-3-642-35997-2.CrossRef

36.

Li G, Cohen JA, Martines C, Ram-Mohan S, Brain JD, Krishnan R, Ai X, Bai Y. Preserving airway smooth muscle contraction in precision-cut lung slices. Sci Rep. 2020;10:6480. https://doi.org/10.1038/s41598-020-63225-y.CrossRefPubMedPubMedCentral

37.

Sonksen P, Sonksen J. Insulin: understanding its action in health and disease. Br J Anaesth. 2000;85:69–79. https://doi.org/10.1093/bja/85.1.69.CrossRefPubMed

38.

Martin C, Held HD, Uhlig S. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:128–36. https://doi.org/10.1007/s002100000264.CrossRefPubMed

39.

Niehof M, Hildebrandt T, Danov O, Arndt K, Koschmann J, Dahlmann F, Hansen T, Sewald K. RNA isolation from precision-cut lung slices (PCLS) from different species. BMC Res Notes. 2017;10:121. https://doi.org/10.1186/s13104-017-2447-6.CrossRefPubMedPubMedCentral

40.

Ruigrok MJR, Tomar J, Frijlink HW, Melgert BN, Hinrichs WLJ, Olinga P. The effects of oxygen concentration on cell death, anti-oxidant transcription, acute inflammation, and cell proliferation in precision-cut lung slices. Sci Rep. 2019;9:16239. https://doi.org/10.1038/s41598-019-52813-2.CrossRefPubMedPubMedCentral

41.

Van Dijk EM, Culha S, Menzen MH, Bidan CM, Gosens R. Elastase-Induced parenchymal disruption and airway hyper responsiveness in mouse precision cut lung slices: toward an Ex vivo COPD model. Front Physiol. 2016;7:657. https://doi.org/10.3389/fphys.2016.00657.CrossRefPubMed

42.

Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol. 1985;1994(77):1051–9. https://doi.org/10.1152/jappl.1994.77.3.1051.CrossRef

43.

Kobayashi M, Ihara M, Sato N, Saeki T, Ozaki S, Ikemoto F, Yano M. A novel ligand, [125I]BQ-3020, reveals the localization of endothelin ETB receptors. Eur J Pharmacol. 1993;235:95–100. https://doi.org/10.1016/0014-2999(93)90825-3.CrossRefPubMed

44.

Uhlig S, von Bethmann AN, Featherstone RL, Wendel A. Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung. Am J Respir Crit Care Med. 1995;152:1449–60. https://doi.org/10.1164/ajrccm.152.5.7582276.CrossRefPubMed

45.

Fontana P, Zufferey A, Daali Y, Reny JL. Antiplatelet therapy: targeting the TxA2 pathway. J Cardiovasc Transl Res. 2014;7:29–38. https://doi.org/10.1007/s12265-013-9529-1.CrossRefPubMed

46.

Shen RF, Tai HH. Thromboxanes: synthase and receptors. J Biomed Sci. 1998;5:153–72. https://doi.org/10.1007/bf02253465.CrossRefPubMed

47.

Uhlig S, Frerichs I. Lungenprotektive Beatmung. Pathophysiologie und Diagnostik. AINS. 2008;43:438–46. https://doi.org/10.1055/s-2008-1081391.CrossRefPubMed

48.

Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–49. https://doi.org/10.1056/nejm200005043421806.CrossRefPubMed

Title: Functional changes in long-term incubated rat precision-cut lung slices
Authors: Sarah Marie Nußbaum
Julia Krabbe
Svenja Böll
Aaron Babendreyer
Christian Martin
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI: https://doi.org/10.1186/s12931-022-02169-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Pneumothorax management: current state of practice in the UK

Higher circulating Trimethylamine N-oxide levels are associated with worse severity and prognosis in pulmonary hypertension: a cohort study

Medium-long term prognosis prediction for idiopathic pulmonary fibrosis patients based on quantitative analysis of fibrotic lung volume

Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa

Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials